FDA Approves Leucovorin for Autism Treatment
Source: What Is Leucovorin, the Medicine Being Approved for Autism Treatment? (2025-09-23)
The FDA has approved leucovorin as a treatment for children with autism spectrum disorder (ASD), marking a significant development in autism therapeutics. The decision follows promising clinical trial results indicating that leucovorin can improve social and communication skills in affected children, offering a new option for families seeking interventions beyond behavioral therapies. Researchers believe leucovorin may work by modulating brain chemistry related to glutamate and folate pathways, which are often implicated in ASD. Experts caution that while the approval is encouraging, leucovorin is not a cure and should be used as part of a comprehensive treatment plan. The approval has sparked discussions about personalized medicine approaches and the need for further studies to understand long-term effects.
More recent coverage
- Global Markets Surge Amid Economic Optimism
- Jake Paul vs. Gervonta Davis Fight Details Revealed
- Comic Book Highlights: Captain America, Batman, Iron Fist
- Nepal Embraces a New Global Identity
- Emraan Hashmi Opens Up About 'Serial Kisser' Label
- Stephen Miller's Speech Sparks Controversy Over Historical Parallels
- Sarah Ferguson Issues Apology to Jeffrey Epstein